Table 1.
ViVan | LoFreq | VPhaser2 | SAMTools pileup | |
---|---|---|---|---|
True positives | 231 | 219 | 196 | 244 |
False positives | 4 | 1 | 2 | 1399 |
True negatives | 31918 | 31921 | 31920 | 30523 |
False negatives | 13 | 25 | 48 | 0 |
sensitivity | 0.947 | 0.898 | 0.803 | 1.000 |
specificity | 1.000 | 1.000 | 1.000 | 0.956 |
PPV | 0.983 | 0.995 | 0.990 | 0.149 |
NPV | 0.999 | 0.998 | 0.995 | 1.000 |
F1-Score | 0.965 | 0.944 | 0.887 | 0.259 |
Simulated DENV population using six sequenced clinical samples sub-sampled at various rates was used to demonstrate ViVan’s performance in the context of real sequencing data
Because the coverage in this data set was low (100×) ViVan’s PPV was the lowest. However, ViVan demonstrated the highest sensitivity out of the three methods, identifying all but one of the variants found in the other. This dataset also highlights the need for sequencing-error aware methods in order to reduce false positive calls such as the ones produced by naïve pileup.